Andrew Chase
Andrew Chase publishes mostly in Hematology, Genetics and Rheumatology, on topics such as Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment and Acute Myeloid Leukemia Research.
- World rank
- #749,304 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #62,701 of 367,258
- Works
- 155
- Citations
- 9.1k
- Citations per work
- 58.5
What does Andrew Chase research?
Andrew Chase's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10567.9%
- Medicine10567.9%
- Everything else3019.4%
- Life Sciences2012.7%
- 1Hematology35% of their works
- 2Genetics19% of their works
- 3Rheumatology11% of their works
- 4Molecular Biology10% of their works
- 5Pathology and Forensic Medicine3% of their works
- 6Immunology3% of their works
Research topics
- Chronic Myeloid Leukemia Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Eosinophilic Disorders and Syndromes
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Hematopoietic Stem Cell Transplantation
Which keywords describe Andrew Chase's research?
The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, Classification, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML and JAK2 Mutation.
- Graft-versus-Host Disease
- Childhood Cancer
- Molecular Profiling
- Genomic Aberrations
- Rituximab
- Fusion Genes
- JAK2 Mutation
- AML
- Classification
- BCR-ABL
- Prognostic Factors
- Imatinib
- Hematopoietic Stem Cells
- Acute Myeloid Leukemia
- Myelofibrosis
- Hypereosinophilic Syndrome
- Chronic Lymphocytic Leukemia
- Lymphoma
- Acute Lymphoblastic Leukemia
- Bone Marrow Niche
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors933 topics
- BCR-ABL871 topic
- Imatinib871 topic
- Classification602 topics
- Hematopoietic Stem Cells602 topics
- AML501 topic
- Acute Myeloid Leukemia501 topic
- JAK2 Mutation501 topic
- Myelofibrosis501 topic
- Fusion Genes481 topic
- Hypereosinophilic Syndrome481 topic
- Rituximab442 topics
- Chronic Lymphocytic Leukemia321 topic
- Genomic Aberrations321 topic
- Lymphoma121 topic
- Molecular Profiling121 topic
- Acute Lymphoblastic Leukemia111 topic
- Childhood Cancer111 topic
- Bone Marrow Niche101 topic
- Graft-versus-Host Disease101 topic
Where does Andrew Chase work?
Andrew Chase's main affiliation in the publication record is Wessex Regional Genetics Laboratory, United Kingdom.
How many publications and citations does Andrew Chase have?
OpenAlex counts 155 works and 9,068 citations for Andrew Chase, an h-index of 46, ranking #749,304 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Andrew Chase. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.